Structure–activity relationships of epolactaene derivatives: structural requirements for inhibition of Hsp60 chaperone activity
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (17) , 4425-4429
- https://doi.org/10.1016/j.bmcl.2004.06.054
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- RIKEN
This publication has 21 references indexed in Scilit:
- A convergent total synthesis of epolactaene: an application of the bridgehead oxiranyl anion strategyTetrahedron, 2003
- Diastereoselective Total Synthesis of Both Enantiomers of EpolactaeneThe Journal of Organic Chemistry, 2002
- A novel lipid compound, epolactaene, induces apoptosis: its action is modulated by its side chain structureBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2001
- Epolactaene, a Novel Neuritogenic Compound in Human Neuroblastoma Cells, Selectively Inhibits the Activities of Mammalian DNA Polymerases and Human DNA Topoisomerase IIBiochemical and Biophysical Research Communications, 2000
- Convergent total synthesis of epolactaene: application of bridgehead oxiranyl anion strategyTetrahedron Letters, 1999
- Asymmetric total synthesis of epolactaene. Part 1: Construction of epoxy-γ-lactam moiety and deduction of absolute stereochemistryTetrahedron, 1999
- Asymmetric Total Synthesis of EpolactaeneChemistry Letters, 1998
- Absolute Configuration and Total Synthesis of (+)-Epolactaene, a Neuritogenic Agent from Penicillium sp. BM 1689-P Active in Human Neuroblastoma CellsThe Journal of Organic Chemistry, 1998
- Neuritogenic Effect of Epolactaene Derivatives on Human Neuroblastoma Cells Which Lack High-Affinity Nerve Growth Factor ReceptorsJournal of Medicinal Chemistry, 1997
- Epolactaene, a Novel Neuritogenic Compound in Human Neuroblastoma Cells, Produced by a Marine Fungus.The Journal of Antibiotics, 1995